Cargando…
Transcription factor E2F4 is an indicator of poor prognosis and is related to immune infiltration in hepatocellular carcinoma
Background: Recent studies have shown that the transcription factor E2F4 is involved in the progression of various tumors, but its expression and influence on immune cell infiltration and biological functions are largely unknown in hepatocellular carcinoma (HCC). Methods: The Cancer Genome Atlas (TC...
Autores principales: | Zheng, Qiuxian, Fu, Qiang, Xu, Jia, Gu, Xinyu, Zhou, Haibo, Zhi, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890309/ https://www.ncbi.nlm.nih.gov/pubmed/33613768 http://dx.doi.org/10.7150/jca.51616 |
Ejemplares similares
-
Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions
por: Zheng, Qiuxian, et al.
Publicado: (2021) -
Uncovering the Association Between m(5)C Regulator-Mediated Methylation Modification Patterns and Tumour Microenvironment Infiltration Characteristics in Hepatocellular Carcinoma
por: Gu, Xinyu, et al.
Publicado: (2021) -
TRIP13 overexpression in hepatocellular carcinoma: implications for poor prognosis and immune cell infiltration
por: Xue, Jiapeng, et al.
Publicado: (2023) -
Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer
por: Shang, Yuanyuan, et al.
Publicado: (2022) -
Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma
por: Li, Mingxing, et al.
Publicado: (2021)